Skip to main content
S. 2039 118th Congress Senate

Cancer Drug Parity Act of 2023

Official title: A bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with suc… Show full official titleShow less

Official title: A bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider.

Introduced: June 15, 2023 Introduced by: Tina Smith Democratic · Minnesota See on congress.gov
Health
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 15, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 15, 2023
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action June 15, 2023

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 1
  • HR 6301 Identical bill Cancer Drug Parity Act of 2023
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 18
All 18 Democratic 9 Republican 7 Independent 1
D
Peters, Gary C.
Michigan · Apr 30, 2024
 D
Booker, Cory A.
New Jersey · Jan 8, 2024
 R
Cramer, Kevin
North Dakota · Nov 27, 2023
Sinema, Kyrsten
· Oct 24, 2023
 D
Reed, Jack
Rhode Island · Oct 16, 2023
 D
Baldwin, Tammy
Wisconsin · Jun 15, 2023
 D
Blumenthal, Richard
Connecticut · Jun 15, 2023
 R
Capito, Shelley Moore
West Virginia · Jun 15, 2023
 R
Hyde-Smith, Cindy
Mississippi · Jun 15, 2023
 I
King, Angus S., Jr.
Maine · Jun 15, 2023
 D
Klobuchar, Amy
Minnesota · Jun 15, 2023
 D
Merkley, Jeff
Oregon · Jun 15, 2023
 R
Moran, Jerry
Kansas · Jun 15, 2023
 R
Murkowski, Lisa
Alaska · Jun 15, 2023
 D
Murphy, Christopher
Connecticut · Jun 15, 2023
 R
Scott, Rick
Florida · Jun 15, 2023
 D
Whitehouse, Sheldon
Rhode Island · Jun 15, 2023
 R
Wicker, Roger F.
Mississippi · Jun 15, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2039: Cancer Drug Parity Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-S-2039/
MLA
"S. 2039: Cancer Drug Parity Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-2039/.
Bluebook (legal)
S. 2039, 118th Cong. (2026), https://openamerica.io/bill/118-S-2039/.
Markdown link
[S. 2039: Cancer Drug Parity Act of 2023](https://openamerica.io/bill/118-S-2039/)
Report a problem